Literature DB >> 30639090

Transdiagnostic neuroimaging in psychiatry: A review.

Serge A Mitelman1.   

Abstract

Transdiagnostic approach has a long history in neuroimaging, predating its recent ascendance as a paradigm for new psychiatric nosology. Various psychiatric disorders have been compared for commonalities and differences in neuroanatomical features and activation patterns, with different aims and rationales. This review covers both structural and functional neuroimaging publications with direct comparison of different psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, conduct disorder, anorexia nervosa, and bulimia nervosa. Major findings are systematically presented along with specific rationales for each comparison.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Autism spectrum disorder; Diffusion tensor imaging; Eating disorders; Magnetic resonance imaging; Obsessive-compulsive disorder; Positron emission tomography; Unipolar and bipolar depression

Year:  2019        PMID: 30639090     DOI: 10.1016/j.psychres.2019.01.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

Review 1.  White Matter Microstructure across the Psychosis Spectrum.

Authors:  Katherine H Karlsgodt
Journal:  Trends Neurosci       Date:  2020-04-26       Impact factor: 13.837

Review 2.  [Brain imaging in schizophrenia : A review of current trends and developments].

Authors:  Igor Nenadić
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

Review 3.  The Comorbidity of Migraine and Restless Legs Syndrome.

Authors:  Semiha Kurt
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

4.  INCloud: integrated neuroimaging cloud for data collection, management, analysis and clinical translations.

Authors:  Qingfeng Li; Lijuan Jiang; Kaini Qiao; Yang Hu; Bing Chen; Xiaochen Zhang; Yue Ding; Zhi Yang; Chunbo Li
Journal:  Gen Psychiatr       Date:  2021-12-23

5.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum.

Authors:  David Watson; Holly F Levin-Aspenson; Monika A Waszczuk; Christopher C Conway; Tim Dalgleish; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey A Hobbs; Giorgia Michelini; Brady D Nelson; Martin Sellbom; Tim Slade; Susan C South; Matthew Sunderland; Irwin Waldman; Michael Witthöft; Aidan G C Wright; Roman Kotov; Robert F Krueger
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 79.683

Review 6.  Translating research findings into clinical practice: a systematic and critical review of neuroimaging-based clinical tools for brain disorders.

Authors:  C Scarpazza; M Ha; L Baecker; R Garcia-Dias; W H L Pinaya; S Vieira; A Mechelli
Journal:  Transl Psychiatry       Date:  2020-04-20       Impact factor: 6.222

Review 7.  Anomalous brain gyrification patterns in major psychiatric disorders: a systematic review and transdiagnostic integration.

Authors:  Daiki Sasabayashi; Tsutomu Takahashi; Yoichiro Takayanagi; Michio Suzuki
Journal:  Transl Psychiatry       Date:  2021-03-17       Impact factor: 6.222

8.  Identifying subtypes of depression in clinician-annotated text: a retrospective cohort study.

Authors:  Benson Kung; Maurice Chiang; Gayan Perera; Megan Pritchard; Robert Stewart
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

9.  Cortical thickness distinguishes between major depression and schizophrenia in adolescents.

Authors:  Zheyi Zhou; Kangcheng Wang; Jinxiang Tang; Dongtao Wei; Li Song; Yadong Peng; Yixiao Fu; Jiang Qiu
Journal:  BMC Psychiatry       Date:  2021-07-20       Impact factor: 3.630

Review 10.  Cortical Microcircuit Mechanisms of Mismatch Negativity and Its Underlying Subcomponents.

Authors:  Jordan M Ross; Jordan P Hamm
Journal:  Front Neural Circuits       Date:  2020-03-31       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.